$65.08 +0.23 (0.355%) Eli Lilly & Co - NYSE

Oct. 1, 2014 | 04:00 PM

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
10/01/2011Tapiero JacquesSVP&Pres., Emerging Markets-5,107$36.97-16.14%
9/30/2011HOOVER R DAVIDDirector229$37.521.81%
9/30/2011HOOVER R DAVIDDirector227$37.811.80%
9/12/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-5,700$35.91-7.69%
8/31/2011Simmons Jeffrey NSVP&Pres.,Elanco Animal Health-1,340$37.17-4.94%
8/31/2011HOOVER R DAVIDDirector240$35.771.96%
8/11/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-5,700$33.94-7.13%
7/29/2011HOOVER R DAVIDDirector226$38.051.88%
7/11/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-5,700$37.39-6.65%
7/06/2011Deane Frank MPresident, Mfg. Operations-5,000$37.20-29.20%
6/30/2011HOOVER R DAVIDDirector229$37.561.95%
6/27/2011Deane Frank MPresident, Mfg. Operations-3,300$36.73-16.16%
6/27/2011Deane Frank MPresident, Mfg. Operations-1,700$36.74-7.68%
6/20/2011Deane Frank MPresident, Mfg. Operations-5,000$37.38-18.43%
6/13/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-5,700$37.25-6.20%
5/31/2011HOOVER R DAVIDDirector219$39.151.92%
5/17/2011HANISH ARNOLD CChief Accounting Officer-3,378$39.12-16.54%
5/11/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-5,700$38.21-5.83%
4/29/2011HOOVER R DAVIDDirector241$35.622.16%
4/20/2011Nobles AnneChief Eth/Cmpl Ofcr & SVP, ERM-12,000$35.98-36.43%
4/11/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-5,700$35.76-5.51%
3/31/2011HOOVER R DAVIDDirector250$34.382.29%
3/11/2011Lundberg Jan MEVP,Science&Tech and Pres. LRL-11,000$34.86-49.21%
3/04/2011Tapiero JacquesSVP&Pres., Emerging Markets-5,000$34.50-17.84%
2/28/2011HOOVER R DAVIDDirector249$34.432.37%
2/16/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-3,100$34.49-2.91%
2/15/2011Rice Derica WEVP-Global Services and CFO-12,441$34.55-23.97%
2/09/2011Deane Frank MPresident, Mfg. Operations-23,435$35.75-46.35%
2/03/2011ARMITAGE ROBERT ASr. VP and General Counsel-10,546$35.36-20.31%
2/03/2011ARMITAGE ROBERT ASr. VP and General Counsel-4,044$35.35-7.22%
2/03/2011ARMITAGE ROBERT ASr. VP and General Counsel-600$35.31-0.84%
2/03/2011ARMITAGE ROBERT ASr. VP and General Counsel-600$35.30-0.83%
2/03/2011ARMITAGE ROBERT ASr. VP and General Counsel-1,500$35.38-3.88%
2/03/2011ARMITAGE ROBERT ASr. VP and General Counsel-26$35.39-0.07%
2/03/2011ARMITAGE ROBERT ASr. VP and General Counsel-5,821$35.32-8.18%
2/03/2011ARMITAGE ROBERT ASr. VP and General Counsel-2,700$35.37-6.52%
2/03/2011ARMITAGE ROBERT ASr. VP and General Counsel-2,394$35.34-4.10%
2/03/2011ARMITAGE ROBERT ASr. VP and General Counsel-6,963$35.33-10.66%
2/01/2011ARMITAGE ROBERT ASr. VP and General Counsel-20,100$34.77-54.09%
2/01/2011Rice Derica WEVP-Global Services and CFO-31,040$34.77-37.42%
2/01/2011Lundberg Jan MEVP,Science&Tech and Pres. LRL-10,981$34.77-32.94%
2/01/2011LECHLEITER JOHN CChairman, President, and CEO-83,114$34.77-29.05%
2/01/2011Deane Frank MPresident, Mfg. Operations-11,815$34.77-18.94%
2/01/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-31,555$34.77-22.86%
1/31/2011HOOVER R DAVIDDirector247$34.792.41%
1/25/2011Mahony SusanSVP, HR & Diversity1,730$34.73111.90%
1/25/2011HANISH ARNOLD CChief Accounting Officer3,415$34.7319.80%
1/25/2011Conterno Enrique ASr. VP & Pres., Lilly Diabetes19,657$34.7377.89%
1/25/2011Simmons Jeffrey NSVP&Pres.,Elanco Animal Health15,694$34.73122.96%
1/25/2011Tapiero JacquesSVP&Pres., Emerging Markets16,670$34.73146.79%
1/25/2011Mahony SusanSVP, HR & Diversity9,297$34.7350.95%
1/25/2011Nobles AnneChief Eth/Cmpl Ofcr & SVP, ERM12,869$34.7364.13%
1/14/2011Carmine Bryce D.EVP and Pres, Lilly Bio-Meds-3,100$34.87-5.16%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (LLY), click here.
  • Showing 201-253 of 253 items
  • <<
  • 1
  • 2
  • 3
Trading Center